[Skip to Navigation]
Sign In
Table.  Polymerase Chain Reaction–Confirmed Secondary COVID-19 Cases in Nonindex Household Members Within 7 Days After Index Case Patient Sampling Datea
Polymerase Chain Reaction–Confirmed Secondary COVID-19 Cases in Nonindex Household Members Within 7 Days After Index Case Patient Sampling Datea
1.
Callaway  E.  Heavily mutated Omicron variant puts scientists on alert.   Nature. 2021;600(7887):21-21. doi:10.1038/d41586-021-03552-wPubMedGoogle ScholarCrossref
2.
European Centre for Disease Prevention and Control. Assessment of the further emergence of the SARS-CoV-2 Omicron VOC in the context of the ongoing transmission in the EU/EEA, 18th update. December 15, 2021. Accessed February 9, 2021. https://www.ecdc.europa.eu/en/publications-data/covid-19-assessment-further-emergence-omicron-18th-risk-assessment
3.
Barnard  RC, Davies  N, Pearson  CAB,  et al. Modelling the potential consequences of the Omicron SARS-CoV-2 variant in England. CMMID Repository. December 11, 2021. Updated December 23, 2021. Accessed December 29, 2021. https://cmmid.github.io/topics/covid19/omicron-england.html
4.
Veneti  L, Bøås  H, Bråthen Kristoffersen  A,  et al.  Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.   Euro Surveill. 2022;27(4):2200077. doi:10.2807/1560-7917.ES.2022.27.4.2200077PubMedGoogle ScholarCrossref
5.
Norwegian Institute of Public Health. Situation report COVID-19—week 50. December 22, 2021. Accessed December 29, 2021. https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/ukerapport-uke-50-13.12---19.12.21.pdf
6.
Norwegian Institute of Public Health. Emergency preparedness register for COVID-19 (Beredt C19). November 24, 2020. Updated August 26, 2021. Accessed December 29, 2021. https://www.fhi.no/en/id/infectious-diseases/coronavirus/emergency-preparedness-register-for-covid-19/
2 Comments for this article
EXPAND ALL
Deserves a Complete Exposition
Binh Ngo, M.D. | Keck USC School of Medicine
This very important contribution from a large population study in Norway has valuable information that is difficult to assess due to clear truncation of the manuscript to meet word counts. It is not clear what "week 52" means. Also, given the suggestion of reduction in protection as months elapse post immunization and as new variants surface, it is essential to determine when precisely individuals were vaccinated. In how many cases had patients received booster shots?
CONFLICT OF INTEREST: Rose Salter Medical Research Foundation
Previous vs Ongoing Disease Exposures
Rujittika Mungmunpuntipantip, PhD | Private Academic Consultant, Bangkok Thailand
This publication gives interesting data on secondary attack rate [1] and may add to a similar publication by the same investigation team from Norway [2].

However the definition of secondary attack rate should be reconsidered. Infection within a family is not uncommon. It might or might not be due to contact with an index case in the family. However, when there is an index case it is possible there might already be another case in the same family, as family members might have a history of travel together with the same prior exposures but with different durations of time
before symptoms appear. Also, there is a chance of infection from outside the family after diagnosis of the first indexed case in the family; for example, provision of services to a family during isolation might be a cause of disease contact.

Rujittika Mungmunpuntipantip, PhD

Dr DY Patil

Adjunct Professor, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria

Pune, India

References

1. Jørgensen SB, Nygård K, Kacelnik,O. Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households JAMA. Published online March 7, 2022. doi:10.1001/jama.2022.3780
2. Telle K, Jørgensen SB, Hart R, Greve-Isdahl M, Kacelnik O. Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study. Eur J Epidemiol. 2021; 36(7): 741–748.

CONFLICT OF INTEREST: None Reported
READ MORE
Research Letter
March 7, 2022

Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households

Author Affiliations
  • 1Norwegian Institute of Public Health, Oslo, Norway
JAMA. 2022;327(16):1610-1611. doi:10.1001/jama.2022.3780

The new SARS-CoV-2 B.1.1.529 Omicron variant has spread rapidly throughout the world,1-3 including in countries such as Norway with 90% primary vaccination and increasing booster vaccination coverage.4,5 To enable alignment of infection control measures with the risk posed by the new variant and avoid excessive strain on health systems, estimates of the transmissibility of the Omicron variant are needed.3,4 We assessed the secondary attack rate of Omicron and B.1.617.2 Delta variants in households in Norway.

Methods

We used individual-level registry data from the Norwegian emergency preparedness register (eTable in the Supplement).6 All Norwegian residents were tracked from December 1, 2021, to January 8, 2022, the period when the Omicron variant increased from less than 5% to greater than 85% of all variant-classified isolates in Norway.4 We excluded single-person households and households with simultaneous index cases or a case in the 3 months before December. The registry includes every polymerase chain reaction (PCR) test performed in Norway. Secondary cases were identified by a positive PCR test result for SARS-CoV-2. Variant analysis by PCR or sequencing was performed for isolates of most index cases. Secondary attack rate was defined as the number of nonindex household members with a positive test result within 7 days after the sample date of the index case, divided by the total number of nonindex household members. It was calculated separately for households in which the index case had the Omicron, Delta, or nonclassified variant. The percentage of household members tested within 7 days was calculated with the same method. Logistic regression models were used to estimate odds ratios (ORs) for secondary infection or testing among nonindex household members in households in which the index case had Omicron (Delta reference), adjusted for the index case’s age, sex, vaccination status, and sampling week. For robustness we estimated the model with additional adjustment for these characteristics of nonindex household members.

The Regional Committees for Medical Research Ethics South East Norway confirmed that external ethical board review was not required. Statistical significance was defined as a 95% CI that excluded 1. Stata version 16 (StataCorp) software was used.

Results

There were 31 220 households with 1 index case (mean age, 30 years; 51% male), comprising 80 957 nonindex members (mean age, 31 years; 50% male), of whom 11 643, 41 015, and 28 299 belonged to a household in which the variant of the index case was Omicron, Delta, or nonclassified, respectively. The mean age of nonindex members of households in which the index case had the Omicron variant was 33 years, and 49% were male, compared with 31 years and 50% for Delta.

Secondary attack rate was 25.1% (95% CI, 24.4%-25.9%) when the variant of the index case was Omicron, 19.4% (95% CI, 19.0%-19.8%) when it was Delta, and 17.9% (95% CI, 17.5%-18.4%) when it was nonclassified (Table). In the adjusted logistic regression model, the OR of nonindex household members testing positive was 1.52 (95% CI, 1.41-1.64) when the variant of the index case was Omicron and 0.93 (95% CI, 0.88-0.98) when it was nonclassified compared with Delta.

Odds ratios were higher for men, unvaccinated individuals, and those older than 30 years, and in week 52. Adjusting also for characteristics of nonindex household members yielded similar ORs (OR, 1.55 [95% CI, 1.44-1.68] for Omicron; OR, 0.93 [95% CI, 0.89-0.98] for nonclassified compared with Delta). Testing of nonindex household members was lower when the index case had the Omicron variant (48.6%; 95% CI, 47.7%-49.5%) than the Delta variant (55.6%; 95% CI, 55.1%-56.1%), but it was higher in the adjusted model (OR, 1.09; 95% CI, 1.02-1.16).

Discussion

Secondary attack rate of SARS-CoV-2 in Norwegian households was moderately higher when the index case had the Omicron variant rather than the Delta variant.

A strength of the study is the use of nationwide individual-level household data from mandatory reporting on all PCR tests in Norway. A limitation is that data on home tests were not available, and that test activity differed between groups. However, the national regulation prescribed that all positive-result home tests be confirmed by a PCR test, and this is also required to obtain an immunity certificate. Thus, most positive test results are probably recorded. Some Omicron cases could go undetected because of milder symptoms. Sampling for variant analysis of index cases was not random, but similar results for Delta and nonclassified variants suggest that selection bias was limited. Also, household members may have been infected by a third-party source, but such potential bias should be similar across variants.

Section Editors: Jody W. Zylke, MD, Deputy Editor; Kristin Walter, MD, Associate Editor.
Back to top
Article Information

Accepted for Publication: February 25, 2022.

Published Online: March 7, 2022. doi:10.1001/jama.2022.3780

Corresponding Author: Kjetil Telle, PhD, Cluster for Health Services Research, Norwegian Institute of Public Health, Box 222, Skoyen, NO-0213 Oslo, Norway (kjte@fhi.no).

Author Contributions: Dr Telle had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Jørgensen, Nygård, Telle.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Jørgensen, Nygård, Telle.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Jørgensen, Kacelnik, Telle.

Administrative, technical, or material support: Telle.

Supervision: Jørgensen.

Conflict of Interest Disclosures: None reported.

References
1.
Callaway  E.  Heavily mutated Omicron variant puts scientists on alert.   Nature. 2021;600(7887):21-21. doi:10.1038/d41586-021-03552-wPubMedGoogle ScholarCrossref
2.
European Centre for Disease Prevention and Control. Assessment of the further emergence of the SARS-CoV-2 Omicron VOC in the context of the ongoing transmission in the EU/EEA, 18th update. December 15, 2021. Accessed February 9, 2021. https://www.ecdc.europa.eu/en/publications-data/covid-19-assessment-further-emergence-omicron-18th-risk-assessment
3.
Barnard  RC, Davies  N, Pearson  CAB,  et al. Modelling the potential consequences of the Omicron SARS-CoV-2 variant in England. CMMID Repository. December 11, 2021. Updated December 23, 2021. Accessed December 29, 2021. https://cmmid.github.io/topics/covid19/omicron-england.html
4.
Veneti  L, Bøås  H, Bråthen Kristoffersen  A,  et al.  Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.   Euro Surveill. 2022;27(4):2200077. doi:10.2807/1560-7917.ES.2022.27.4.2200077PubMedGoogle ScholarCrossref
5.
Norwegian Institute of Public Health. Situation report COVID-19—week 50. December 22, 2021. Accessed December 29, 2021. https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/ukerapport-uke-50-13.12---19.12.21.pdf
6.
Norwegian Institute of Public Health. Emergency preparedness register for COVID-19 (Beredt C19). November 24, 2020. Updated August 26, 2021. Accessed December 29, 2021. https://www.fhi.no/en/id/infectious-diseases/coronavirus/emergency-preparedness-register-for-covid-19/
×